Compare

CJC-1295 vs Sermorelin

Two growth-hormone-releasing peptides compared - how they differ and how a physician chooses.

Medically reviewed by Charles Kamen, MD, board-certified neurologist ·

CJC-1295 and sermorelin are both growth-hormone-releasing hormone (GHRH) analogs. Rather than adding growth hormone directly, they signal the pituitary to release it. The useful comparison is how long each acts and whether either fits a particular protocol.

At LiveNow Longevity, Dr. Charles Kamen, MD reviews your labs and history before sermorelin is considered. CJC-1295 has no FDA-approved form or compounding pathway, so it is covered here for reference. This is an educational comparison, not medical advice or a substitute for evaluation.

Conceptual molecular sculpture with linked spheres
Conceptual molecular illustration.
CJC-1295Sermorelin
ClassModified (longer-acting) GHRH analogGHRH(1–29) analog
Duration of actionExtended (the DAC form lasts days)Short - mimics natural pulsatile GH release
Often combined withA GHRP such as ipamorelinUsed alone or with a GHRP
FDA statusNot FDA-approved; 503A nomination withdrawnPreviously FDA-approved (Geref, since discontinued); now compounded
Typical use contextFewer injections, steadier signalMore physiologic, pulse-like signal
How we decideReference only: no compounding pathwayDetermined after evaluation

The practical answer: Both work upstream - telling your own body to release growth hormone rather than replacing it. Sermorelin gives a shorter, more pulse-like signal; CJC-1295 acts longer and is often paired with a GHRP. Only sermorelin has a compounding pathway, and whether it fits you is a medical decision made after evaluation.

Questions people ask

What is the difference between CJC-1295 and sermorelin?

Both are GHRH analogs that stimulate your own pituitary to release growth hormone. Sermorelin is short-acting and mimics the body’s natural pulses; CJC-1295 is modified to act longer and is often combined with a GHRP like ipamorelin. Only sermorelin has a compounding pathway; whether it is appropriate is determined after evaluation.

Are CJC-1295 and sermorelin FDA-approved?

Sermorelin was previously FDA-approved as Geref, which has since been discontinued; it is now used as a compounded peptide. CJC-1295 is not FDA-approved, and its nomination for the 503A bulks list was withdrawn, so it has no compounding pathway.

Is one better than the other?

Neither is universally better. Sermorelin gives a more pulse-like, physiologic signal; CJC-1295 gives a longer-acting, steadier one with fewer injections. Only sermorelin can be compounded, and whether it suits your history, labs, and goals is determined by Dr. Kamen after evaluation.

What is the first step?

Book online or call (702) 808-2650 to schedule your evaluation in Las Vegas.

A physician can help you decide

Which one is right for you?

That is a medical decision - and exactly what the $88 evaluation is for. Dr. Charles Kamen, MD reviews your labs, history, and goals and recommends the option that fits you.

Visit our clinic in Las Vegas

Ready to start your longevity care?

Book your $88 evaluation with Dr. Kamen today, online, by phone, or by text.

Prefer to talk? Call (702) 808-2650 or text us to book.

Physician-led peptide therapy in Las Vegas. Visit our clinic

Also serving Henderson - or explore semaglutide weight loss in Las Vegas.